Susan Thronson, a director at Trulieve Cannabis (OTC:TCNNF) Corp. (OTC:TRUL), recently purchased 3,968 subordinate voting shares of the company. The shares were acquired at a price of $6.30 each, amounting to a total transaction value of $24,998. Following this purchase, Thronson holds a direct ownership of 26,463 shares in the company. Additionally, through the Thronson Family Trust UA, she indirectly owns 5,772 shares. This transaction reflects Thronson's ongoing investment in Trulieve Cannabis, a leading player in the medicinal chemicals and botanical products industry.
InvestingPro Insights
While Susan Thronson's recent purchase of Trulieve Cannabis Corp. (OTC:TRUL) shares demonstrates insider confidence, investors should consider additional factors when evaluating the company's potential. According to InvestingPro data, Trulieve's stock has experienced significant volatility, with a 99.9% decline in price over the past three months. This aligns with an InvestingPro Tip highlighting that the stock generally trades with high price volatility.
Another InvestingPro Tip reveals that Trulieve suffers from weak gross profit margins, which could impact the company's financial health and growth prospects. This information, combined with the average daily trading volume of 0.07 million USD over the past three months, suggests that investors should carefully assess the company's fundamentals and market position.
For a more comprehensive analysis, InvestingPro offers additional tips and insights that could prove valuable for investors considering Trulieve Cannabis Corp. In fact, there are 7 additional tips available on the InvestingPro platform, providing a deeper understanding of the company's financial situation and market performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.